Bio-Matrix Scientific Group Finalizing Patent Applications for Three New Devices
Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXG - News) announced today that it is preparing to file three new patent applications. These patent applications cover additional stem cell and tissue management devices. The Company anticipates the applications will be filed sometime next week. This will mean Bio-Matrix Scientific Group will have four patent applications submitted so far this year.
Dr. Philip Watts, Director of Research and Development for Bio-Matrix, is finalizing the changes on the Matrix Lock, the Matrix Secure Transfer, and the Matrix Handle Adapter. Currently, the Company’s engineering consulting firm is working with Dr. Watts on these devices, representing what the Company believes will be the next generations of their type.
These three new patent applications, once finalized, represent another significant milestone for Bio-Matrix in the development of its Medical and Research Devices. These patent applications also demonstrate the Company’s commitment to becoming a leader in stem cell and tissue management Instrumentation.
More information will be available shortly on the Company’s website: www.BMXGonline.com.
About Bio-Matrix Scientific Group Inc.:
Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXG - News) are StemCells Inc. (NASDAQ:STEM - News), Thermogenesis Corporation (NASDAQ:KOOL - News) and Regeneration Technologies Inc. (NASDAQ:RTIX - News).
DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
- Contact Information
- Investor Relations
- Investor Relations
- Bio-Matrix Scientific Group Inc.,
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.